Anna Akrami

1.1k citations
7 papers · 491 indexed · h-index 5
Topics
Crystallization and Solubility Studies (2 papers)Drug Solubulity and Delivery Systems (2 papers)Hormonal Regulation and Hypertension (2 papers)
Partner nations
United States

In The Last Decade

Anna Akrami

7 papers receiving 463 citations

Peers

Anna Akrami
Comparison fields: 5 of 62
  • Pharmaceutical Science 291
  • Materials Chemistry 280
  • Physical and Theoretical Chemistry 138
  • Spectroscopy 85
  • Molecular Biology 75
Replace Koji Shiraki with:
Koji Shiraki Japan
Jonas H. Fagerberg Sweden
Yasushi Shono Japan
Ajit B. Thakur United States
Enxian Lu United States
Sundani Nurono Soewandhi Indonesia
Maurizio Valleri Italy
Jennifer Tavares Jacon Freitas Brazil
Katrine Tarp Jensen Denmark
Georgia Kasten Denmark
Anna Akrami relative to Koji Shiraki Japan Koji Shiraki's profile →
Citations per field
00.5×1.5×
Koji Shiraki · 1×
Citations per year

Countries citing papers authored by Anna Akrami

Since Specialization
Citations

This map shows the geographic impact of Anna Akrami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Akrami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Akrami more than expected).

Fields of papers citing papers by Anna Akrami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Akrami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Akrami. The network helps show where Anna Akrami may publish in the future.

Co-authorship network of co-authors of Anna Akrami

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Akrami. A scholar is included among the top collaborators of Anna Akrami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Akrami. Anna Akrami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 12
2 3
3 3
4 33
5 181
6 121
7 138

About Anna Akrami

Anna Akrami is a scholar working on Pharmaceutical Science, Small Animals and Endocrinology, Diabetes and Metabolism, having authored 7 papers that have together received 491 indexed citations. Recurring topics across this work include Crystallization and Solubility Studies (2 papers), Drug Solubulity and Delivery Systems (2 papers) and Hormonal Regulation and Hypertension (2 papers). The work is most often cited by research in Pharmaceutical Science (291 citations), Physical and Theoretical Chemistry (138 citations) and Materials Chemistry (280 citations). Anna Akrami has collaborated with scholars based in United States. Frequent co-authors include Sekhar Surapaneni, Lan Li, Ping Gao, Jack Hu, Francisco J. Álvarez, Sesha Neervannan, Anu Gore, Mark J. Rose, Dražen Ostović and Rashid Syed. Their work appears in journals such as Journal of Pharmaceutical Sciences, Molecular Pharmaceutics and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026